1xbet 프로모션 코드., Ltd.
1xbet 프로모션 코드, Ltd.

1xbet 프로모션 코드., Ltd. (Head Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) (hereafter, Otsuka Pharmaceutical) and Fuso Pharmaceutical Industries, Ltd. (Head Office: Chuo-ku, Osaka, Japan; President: Mikio Toda) (hereafter, Fuso) today announced that they concluded an agreement on the manufacturing and commercialization in Japan of a therapeutic cancer vaccine OTS102, which is expected to inhibit angiogenesis.

Under the terms of agreement, Fuso, which was granted the exclusive rights to manufacture and commercialize OTS102 in Japan from OncoTherapy Science, Inc. (OTS), has sublicensed the manufacturing and commercialization rights to 1xbet 프로모션 코드. 1xbet 프로모션 코드 shall pay Fuso an upfront payment as well as milestone payments and royalties. OTS will continue to develop OTS102, and 1xbet 프로모션 코드 and Fuso will bear the development costs. After OTS102 is launched, 1xbet 프로모션 코드 will manufacture the product, and both Otsuka Pharmacetuical and Fuso will commercialize the product under their own brand names.

1xbet 프로모션 코드 obtained the exclusive rights from OTS to develop, manufacture and commercialize several therapeutic peptide vaccines for pancreatic cancer, including OTS11101, in January 2008. With the agreement reached this time, 1xbet 프로모션 코드 has obtained additional rights to manufacture and commercialize OTS102 in Japan. 1xbet 프로모션 코드 will make continuous efforts on the research and development of cancer peptide vaccines, which are expected to become an innovative approach to cancer treatment, so as to provide new cancer treatment options on a worldwide basis.

1xbet 프로모션 코드., Ltd. strives to contribute to the health of people around the world based on its corporate philosophy of 'Otsuka-people creating new products for better health worldwide.'

Corporate In1xbet 프로모션 코드mation

Onco1xbet 프로모션 코드rapy Science, Inc.

1xbet 프로모션 코드, Ltd.